A high dose of Wegovy that helped people lose 21% of their weight in a clinical trial was just approved
Novo Nordisk’s 7.2 mg dose of Wegovy will compete against Lilly’s GLP-1 injection.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the briefHow this story developed
2 reports over 1h 48m-
Market Watch You're reading this A high dose of Wegovy that helped people lose 21% of their weight in a clinical trial was just approved Neutral 0



